Incidence, risk factors, and prognosis of inhospital heart failure after percutaneous coronary intervention: Insight from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

Outcome after coronary artery bypass graft surgery, coronary angioplasty and stenting

“…Likewise in good agreement with other studies [23][24][25] we identified serum lipids [24] and a history of myocardial infarction [25] as predictors of MACE.…”

“…Consistent with other studies [15,17,[22][23][24], the present analyses identified age [15,23], pulse pressure [15], current smoking [15], diabetes mellitus [17,22,23], serum lipids [24], a prior history of myocardial infarction [25] and left ventricular ejection fraction [22] as determinants of mortality in invasively treated CAD patients. Likewise in good agreement with other studies [23][24][25] we identified serum lipids [24] and a history of myocardial infarction [25] as predictors of MACE.…”

The impact of clinical and angiographic factors on percutaneous coronary angioplasty outcomes in patients with acute ST-elevation myocardial infarction

“…There are studies only about predictors of HF occurrence after PCI. These studies revealed that independent predictors of post-procedural HF are female sex, age ≥ 60 years, diabetes, dyslipidemia, prior HF, prior MI, anterior STEMI, and baseline TIMI flow grade 0 [17, 18]. Cotter et al reported that age, co-morbidities, and markers of HF severity were moderately predictive of WHF after admission for acute HF.…”

Depressive Symptoms Affect the Relationship of N-Terminal Pro B-Type Natriuretic Peptide to Cardiac Event-Free Survival in Patients With Heart Failure

“…The following variables have been identified as traditional risk factors which are associated with prognosis of patients with HF in prior resesearches5, 24, 27-32; older age, female gender, ischemic heart disease as underlying HF etiology, low BMI, worse NYHA functional class, lower LVEF, and comorbidities such as diabetes and renal dysfunction are associated with poor prognosis in patients with HF. Data on age, gender, etiology of HF, BMI, NYHA functional class, LVEF, and total comorbidity score using the Charlson comorbidity index were collected through patient interview and medical record review.…”